Clinical impact of pre-hypertension on the risk of cancer in male and female subjects.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
19 06 2020
19 06 2020
Historique:
received:
23
10
2019
accepted:
19
05
2020
entrez:
21
6
2020
pubmed:
21
6
2020
medline:
15
12
2020
Statut:
epublish
Résumé
There are few studies assessing pre-hypertension and an impaired fasting glucose (IFG) and their combined effects on the cancer risk. We investigated the impact of pre-hypertension on cancer risk and IFG, and their combined effects on the cancer risk. This study included 371,762 subjects (≥40 years) who had never been diagnosed with hypertension, diabetes mellitus (DM), and cancer before. During a mean follow-up of 10.06 ± 1.86 years, 35,605 (9.58%) of the subjects developed cancer. In men only, cancer risk was significantly increased with an increase in the blood pressure (BP) (P for trend < 0.001), and were increased in the hypertension range, but not the pre-hypertension range. When analyzing the combination effect of BP and fasting glucose, cancer risks were serially increased with an increase in the fasting glucose in a dose-dependent manner, but not with an increase in BP. These results were more consistently significant in the never-smoker and non-alcohol drinking groups. However, in women, there was no significant difference. In conclusions, increased BP status or the fasting serum glucose level status were associated with cancer risk in men. Furthermore, the combination of both pre-hypertension and IFG also was associated with a cancer risk in men.
Identifiants
pubmed: 32561792
doi: 10.1038/s41598-020-66653-y
pii: 10.1038/s41598-020-66653-y
pmc: PMC7305195
doi:
Substances chimiques
Blood Glucose
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
9974Références
McGuire, S. World Cancer Report 2014. Geneva, Switzerland: World Health Organization, International Agency for Research on Cancer, WHO Press, 2015. Advances in Nutrition 7, 418–419 (2016).
doi: 10.3945/an.116.012211
Stocks, T. et al. Metabolic factors and the risk of colorectal cancer in 580,000 men and women in the metabolic syndrome and cancer project (Me-Can). Cancer 117, 2398–2407 (2011).
doi: 10.1002/cncr.25772
Carreras-Torres, R. et al. The Role of Obesity, Type 2 Diabetes, and Metabolic Factors in Pancreatic Cancer: A Mendelian Randomization Study. Journal of the National Cancer Institute 109 (2017).
Muntner, P. et al. Potential U.S. Population Impact of the 2017 American College of Cardiology/American Heart Association High Blood Pressure Guideline. Circulation (2017).
World Health Organization. Global report on diabetes. Geneva, switzerland. (2016).
Genuth, S. et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes care 26, 3160–3167 (2003).
doi: 10.2337/diacare.26.12.3331
James, P. A. et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 311, 507–520 (2014).
doi: 10.1001/jama.2013.284427
Lee, S. S. et al. Clinical implication of an impaired fasting glucose and prehypertension related to new onset atrial fibrillation in a healthy Asian population without underlying disease: a nationwide cohort study in Korea. European heart journal 38, 2599–2607 (2017).
doi: 10.1093/eurheartj/ehx316
Stocks, T. et al. Blood pressure and risk of cancer incidence and mortality in the Metabolic Syndrome and Cancer Project. Hypertension (Dallas, Tex.: 1979) 59, 802–810 (2012).
doi: 10.1161/HYPERTENSIONAHA.111.189258
Huang, Y. et al. Prediabetes and the risk of cancer: a meta-analysis. Diabetologia 57, 2261–2269 (2014).
doi: 10.1007/s00125-014-3361-2
Jee, S. H. et al. Fasting serum glucose level and cancer risk in Korean men and women. Jama 293, 194–202 (2005).
doi: 10.1001/jama.293.2.194
Crawley, D. J. et al. Serum glucose and risk of cancer: a meta-analysis. BMC cancer 14, 985 (2014).
doi: 10.1186/1471-2407-14-985
Hirakawa, Y. et al. Association between glucose tolerance level and cancer death in a general Japanese population: the Hisayama Study. American journal of epidemiology 176, 856–864 (2012).
doi: 10.1093/aje/kws178
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Personal habits and indoor combustions. Volume 100 E. A review of human carcinogens. Iarc Monographs on the Evaluation of Carcinogenic Risks to Humans 100, 1–538 (2012).
pmcid: 4781577
Alberg, A. J., Shopland, D. R. & Cummings, K. M. The 2014 Surgeon General’s Report: Commemorating the 50th Anniversary of the 1964 Report of the Advisory Committee to the US Surgeon General and Updating the Evidence on the Health Consequences of Cigarette Smoking. American journal of epidemiology 179, 403–412 (2014).
doi: 10.1093/aje/kwt335
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Alcohol consumption and ethyl carbamate. Iarc Monographs on the Evaluation of Carcinogenic Risks to Humans 96, 3–1383 (2010).
pmcid: 4781168
Seong, S. C. et al. Cohort profile: the National Health Insurance Service-National Health Screening Cohort (NHIS-HEALS) in Korea. BMJ open 7, e016640 (2017).
doi: 10.1136/bmjopen-2017-016640
Williams, B. et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. European heart journal 39, 3021–3104 (2018).
doi: 10.1093/eurheartj/ehy339
Wall, H. K., Hannan, J. A. & Wright, J. S. Patients With Undiagnosed Hypertension: Hiding in Plain Sight. JAMA 312, 1973–1974 (2014).
doi: 10.1001/jama.2014.15388
Cowie, C. C. et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999–2002. Diabetes care 29, 1263–1268 (2006).
doi: 10.2337/dc06-0062
Jee, S. H. et al. Body mass index and cancer risk in Korean men and women. International journal of cancer 123, 1892–1896 (2008).
doi: 10.1002/ijc.23719
Parr, C. L. et al. Body-mass index and cancer mortality in the Asia-Pacific Cohort Studies Collaboration: pooled analyses of 424,519 participants. The Lancet. Oncology 11, 741–752 (2010).
doi: 10.1016/S1470-2045(10)70141-8
Jee, S. H. et al. Body-mass index and mortality in Korean men and women. The New England journal of medicine 355, 779–787 (2006).
doi: 10.1056/NEJMoa054017
Charlson, M. E., Pompei, P., Ales, K. L. & MacKenzie, C. R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Journal of chronic diseases 40, 373–383 (1987).
doi: 10.1016/0021-9681(87)90171-8
Seo, H. J., Oh, I. H. & Yoon, S. J. A comparison of the cancer incidence rates between the national cancer registry and insurance claims data in Korea. Asian Pacific journal of cancer prevention: APJCP 13, 6163–6168 (2012).
doi: 10.7314/APJCP.2012.13.12.6163
Jung, K. W. et al. Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2014. Cancer research and treatment: official journal of Korean Cancer Association 49, 292–305 (2017).
doi: 10.4143/crt.2017.118
Ferlay, J. et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136, E359–86 (2015).
doi: 10.1002/ijc.29210
Christakoudi, S. et al. Blood pressure and risk of cancer in the European Prospective Investigation into Cancer and Nutrition. International journal of cancer, https://doi.org/10.1002/ijc.32576 (2019).
Radisauskas, R., Kuzmickiene, I., Milinaviciene, E. & Everatt, R. Hypertension, serum lipids and cancer risk: A review of epidemiological evidence. Medicina (Kaunas, Lithuania) 52, 89–98 (2016).
doi: 10.1016/j.medici.2016.03.002
Chow, W. H., Gridley, G., Fraumeni, J. F. Jr. & Jarvholm, B. Obesity, hypertension, and the risk of kidney cancer in men. The New England journal of medicine 343, 1305–1311 (2000).
doi: 10.1056/NEJM200011023431804
Haggstrom, C. et al. Metabolic factors associated with risk of renal cell carcinoma. PloS one 8, e57475 (2013).
doi: 10.1371/journal.pone.0057475
Chow, W. H., Dong, L. M. & Devesa, S. S. Epidemiology and risk factors for kidney cancer. Nature reviews. Urology 7, 245–257 (2010).
doi: 10.1038/nrurol.2010.46
Wang, M. et al. Cancer risk among patients with type 2 diabetes mellitus: a population-based prospective study in China. Scientific reports 5, 11503 (2015).
doi: 10.1038/srep11503
Buysschaert, M. & Sadikot, S. Diabetes and cancer: a 2013 synopsis. Diabetes & metabolic syndrome 7, 247–250 (2013).
doi: 10.1016/j.dsx.2013.08.001
Giovannucci, E. et al. Diabetes and Cancer: A consensus report. Diabetes care 33, 1674–1685 (2010).
doi: 10.2337/dc10-0666
Stocks, T. et al. Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohorts. PLoS medicine 6, e1000201 (2009).
doi: 10.1371/journal.pmed.1000201
Whelton, P. K. et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension (Dallas, Tex.: 1979) 71, 1269–1324 (2018).
doi: 10.1161/HYP.0000000000000066